Affiliation:
1. Computer-Aided Drug Design
2. Orion Pharma
3. FI-02101 Espoo
4. Finland
5. Division of Pharmaceutical Chemistry and Technology
6. Faculty of Pharmacy
7. University of Helsinki
8. FI-00014 Helsinki
Publisher
Royal Society of Chemistry (RSC)
Subject
Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry
Reference30 articles.
1. Kinase Drug Discovery – What’s Next in the Field?
2. US Food and Drug Administration approved small molecule protein kinase inhibitors, http://www.brimr.org/PKI/PKIs.htm
3. A small molecule–kinase interaction map for clinical kinase inhibitors
4. PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand–receptor interactions
5. J. E. S. Wikberg , M.Lapinsh and P.Prusis, Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG, 2004, pp. 289–309
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献